96.3%
SirolimusRapamunecardiac rhabdomyomacardiac rhabdomyomastuberous sclerosisEuropean Medicines AgencyPfizer Limitedrespiratory support
…een administered. The 2nd level was reported at 52.4nanogram/ml.Sirolimus levels continued to be monitored; 18 days after the last dose t…